Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

BACKGROUND: We conducted this study to describe the clinical characteristics, microbiology, and outcomes of patients treated with ceftazidime-avibactam (CZA) for a range of multidrug-resistant Gram-negative (MDR-GN) infections. METHODS: This is a multicenter, retrospective cohort study conducted at...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Jorgensen, Sarah C J, Trinh, Trang D, Zasowski, Evan J, Lagnf, Abdalhamid M, Bhatia, Sahil, Melvin, Sarah M, Steed, Molly E, Simon, Samuel P, Estrada, Sandra J, Morrisette, Taylor, Claeys, Kimberly C, Rosenberg, Joshua R, Davis, Susan L, Rybak, Michael J
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Major Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6934163/
https://ncbi.nlm.nih.gov/pubmed/31890725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz522
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky